Skip to main content

Prime Movers Lab Fund I LP's Form 4 filing

Vaxxinity, Inc. (VAXX) · filed Sep 8, 2023

Accession no.
0001062993-23-017880
Filed
Sep 8, 2023, 6:05 PM ET
Trade date
Sep 6-8, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 15 non-derivative transactions. Open-market sales total $168.6K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Prime Movers Lab Fund I LPCIK 000175163110% Owner
Sloss DakinCIK 000187541110% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 6, 2023Class A Common StockSSaleDisposed−1,251$1.88F1−$2,354.762,063,776Indirect
Sep 6, 2023Class A Common StockSSaleDisposed−5,308$1.88F1−$9,991.258,759,064Direct
Sep 6, 2023Class A Common StockSSaleDisposed−507$1.88F1−$954.33835,992Indirect
Sep 6, 2023Class A Common StockSSaleDisposed−892$1.88F1−$1,679.011,472,208Indirect
Sep 6, 2023Class A Common StockSSaleDisposed−2,189$1.88F1−$4,120.353,612,849Indirect
Sep 7, 2023Class A Common StockSSaleDisposed−4,786$1.79F8−$8,553.542,058,990Indirect
Sep 7, 2023Class A Common StockSSaleDisposed−20,312$1.79F8−$36,301.618,738,752Direct
Sep 7, 2023Class A Common StockSSaleDisposed−1,939$1.79F8−$3,465.38834,053Indirect
Sep 7, 2023Class A common stockSSaleDisposed−3,413$1.79F8−$6,099.711,468,795Indirect
Sep 7, 2023Class A common stockSSaleDisposed−8,378$1.79F8−$14,973.163,604,471Indirect
Sep 8, 2023Class A common stockSSaleDisposed−5,911$1.67F9−$9,871.372,053,079Indirect
Sep 8, 2023Class A common stockSSaleDisposed−25,089$1.67F9−$41,898.638,713,663Direct
Sep 8, 2023Class A Common StockSSaleDisposed−2,395$1.67F9−$3,999.65831,658Indirect
Sep 8, 2023Class A common stockSSaleDisposed−4,217$1.67F9−$7,042.391,464,578Indirect
Sep 8, 2023Class A common stockSSaleDisposed−10,349$1.67F9−$17,282.833,594,122Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price of $1.8823 per share represents a weighted average of purchase prices ranging from $1.85 to $1.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

Referenced by the price of 5 transactions in Table I.

F8

The price of $1.7872 per share represents a weighted average of purchase prices ranging from $1.75 to $1.86 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

Referenced by the price of 5 transactions in Table I.

F9

The price of $1.6700 per share represents a weighted average of purchase prices ranging from $1.60 to $1.82 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

Referenced by the price of 5 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)